An SSSI for clonidine 150mcg

Megan Haggan 22/12/2025

The TGA has announced that Catapres (clonidine) 150 microgram tablets will be in shortage from December 2025 to April 2026 Clinect has told the Therapeutic Goods Administration that the medicine will be subject to the shortage due to manufacturing issues. Catapres is the only brand of clonidine 150mcg tablets supplied in Australia. However, the TGA

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

An SSSI for clonidine 150mcg

Previous ‘This agreement sets a new standard’

Next Research Roundup

MENU

ajp.com.au

Previous ‘This agreement sets a new standard’

Next Research Roundup

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.